National Cancer Institute, Cancer Therapy Evaluation Program

Form 483

Bethesda, Maryland, United StatesFEI 3010830399Issued July 17, 2014

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3010830399.

Observations4

Issue DateJuly 17, 2014

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: National Cancer Institute, Cancer Therapy Evaluation Program
Location: Bethesda, Maryland, United States
FEI Number: 3010830399
Product Type: Drugs
Issue Date: July 17, 2014
Country: United States

Inspection History, 2014 to 2020

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

National Cancer Institute, Cancer Therapy Evaluation Program FDA Form 483, Bethesda, Maryland, July 17, 2014